Skip to content

Enhanced external counterpulsation(EECP) for atherosclerotic stroke study-A pilot study

Enhanced external counterpulsation(EECP) for atherosclerotic stroke study-A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000679
Enrollment
Unknown
Registered
2003-03-15
Start date
2004-05-03
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Interventions

Two groups:External Counterpulsation 35 one- hour sessions over a 7 week period

Sponsors

Division of Neurology, Department of Medicine& Therapeutics, CUHK
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1. Patient is 18 or above; 2. Clinical evidence of cerebral infarct or transient ischaemic attack in preceding 6 months with relevant large artery occlusive disease at MRA examination; 3. Modified Rankin score (mRS) =3; 4. Normal platelet count and coagulation profile; 5. Signed informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1. Any medical condition that would not allow the patient to adhere to the protocol or complete the study; 2. Patients with hemorrhagic diathesis, concurrent anti-coagulation treatment, or history of primary intracranial hemorrhage; 3. Other non-ischemic intra-cerebral pathology, e.g. brain tumor, vascular malformation, etc.; 4. Clinical evidence of arrhythmias, significant valvular heart disease on echocardiography, or aortic dissection; 5. Thrombophlebitis, ulcers or chronic skin infection of the lower limbs; 6. Clinical evidence of active malignancy; 7. Patients with pre-proliferative, or proliferative diabetic retinopathy.

Design outcomes

Primary

MeasureTime frame
change in NIHSS and cerebral blood Flow(CVIQ) at end of week 7 and 14;

Secondary

MeasureTime frame
recurrent stroke Percentage of patients with favorable outcome (mRS=, Barthel Index) at end of week 7 and 14;

Countries

China

Contacts

Public ContactDr. Ka Sing Wong
jinghaohan@hotmail.com+852 2632-3144

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026